Open access
Jul 2026
Discovery of isokurarinone as an ATCase-engaging lead with potent activity against methicillin-resistant Staphylococcus aureus
Findings support the notion of ATCase as a metabolism-guided target for MRSA and nominate isokurarinone as a promising lead scaffold for therapeutic development.
Xin-Yuan Cao, Xiaorong Yang, Lixia Dai et al.
· Virulence · 0 citations